|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 22, 2019 |
Title |
Global transcriptomic analyses of the candida albicans response to treatment with a novel inhibitor of filamentation |
Organism |
Candida albicans |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The opportunistic pathogenic fungus Candida albicans can cause devastating infections in severely compromised patients. Its ability to undergo a morphogenetic transition from yeast to filamentous forms allows it to penetrate tissues and cause damage, and the expression of a number of pathogenetic mechanisms are also coordinately regulated with this yeast-to-hyphae conversion. Therefore, it is widely considered that filamentation represents one of the main virulence factors of C. albicans. We have previously identified N-[3-(allyloxy)-phenyl]-4-methoxybenzamide (compound 9029936) as the lead compound in a series of small molecule inhibitors of C. albicans filamentation, and characterized its activity, both in vitro and in vivo, as a promising candidate for the development of alternative anti-virulence strategies for the treatment of C. albicans infections. Here we have performed RNA sequencing analysis of samples obtained from C. albicans cells grown under filament-inducing conditions in the presence or absence of this compound. Overall treatment with compound 9029936 resulted in 618 up-regulated and 702 down-regulated genes. Not surprisingly some of the top down-regulated genes included well characterized genes associated with filamentation and virulence such as SAP5, ECE1 (candidalysin), and ALS3, as well as genes that impact metal chelation and utilization. Gene ontology analysis revealed an over-representation of cell adhesion, iron transport, filamentation, biofilm formation, and pathogenesis processes among down-regulated genes as result of treatment with this leading compound. Interestingly, the top up-regulated genes pointed to an enhancement of vesicular transport pathways, and in particular SNARE interactions.
|
|
|
Overall design |
C. albicans SC5314 strain was grown overnight as described above, washed with PBS and used to inoculate YPD containing 10% fetal bovine serum at a 1:30 dilution and incubated at 37 C for 90 minutes in the presence or absence of compound 9029936 at 5 uM. Total RNA was extracted by using a hot acid phenol protocol. Three biological replicates were obtained for each condition (treated and untreated).
|
|
|
Contributor(s) |
Romo JA, Zhang H, Hong C, Wang Y, Lopez-Ribot JL |
Citation(s) |
31511371 |
|
Submission date |
Aug 21, 2019 |
Last update date |
Nov 21, 2019 |
Contact name |
Yufeng Wang |
E-mail(s) |
yufeng.wang@utsa.edu
|
Phone |
2104586492
|
Organization name |
University of Texas at San Antonio
|
Street address |
One UTSA Circle
|
City |
San Antonio |
State/province |
TX |
ZIP/Postal code |
78249 |
Country |
USA |
|
|
Platforms (1) |
GPL15645 |
Illumina HiSeq 2000 (Candida albicans) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA561338 |
SRA |
SRP218989 |
Supplementary file |
Size |
Download |
File type/resource |
GSE136116_edgeR.output.csv.gz |
135.4 Kb |
(ftp)(http) |
CSV |
GSE136116_raw.counts.txt.gz |
79.4 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|